Pulse Biosciences, Inc.
PLSE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,015,195 | $1,080,057 | $1,016,709 |
| - Cash | $95,214 | $106,349 | $119,279 | $118,038 |
| + Debt | $6,371 | $8,245 | $8,577 | $8,898 |
| Enterprise Value | – | $917,091 | $969,355 | $907,569 |
| Revenue | $86 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$193 | -$267 | $0 | $0 |
| % Margin | -224.4% | – | – | – |
| EBITDA | -$19,129 | -$18,901 | -$17,761 | -$19,974 |
| % Margin | -22,243% | – | – | – |
| Net Income | -$19,385 | -$19,168 | -$16,795 | -$19,385 |
| % Margin | -22,540.7% | – | – | – |
| EPS Diluted | -0.29 | -0.28 | -0.25 | -0.33 |
| % Growth | -3.6% | -12% | 24.2% | – |
| Operating Cash Flow | -$13,039 | -$12,807 | -$13,521 | -$9,144 |
| Capital Expenditures | -$62 | -$103 | -$45 | -$53 |
| Free Cash Flow | -$13,101 | -$12,910 | -$13,566 | -$9,197 |